Study of Subcutaneous Campath-1H in Patients With B-Cell CLL and Residual Disease After Chemotherapy

计划入组 31 人 · 首次发布于 2008 年 12 月 3 日

Pentostatin, Cyclophosphamide, and Rituximab Followed By Campath-1H in Patients With Relapsed or Refractory B-Cell CLL

计划入组 102 人 · 首次发布于 2003 年 12 月 11 日

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

计划入组 450 人 · 首次发布于 2009 年 6 月 1 日

CLL-1.CAR T cells,Baylor College of Medicine

CLL1-TDB

CLL-502

German CLL Study Group

Germany

Gamida Cell

Israel

GAMIDA CELL INC.

United States

FDA Updates Labeling for Sandoz Fludarabine in B-Cell CLL Treatment via Project Renewal

FDA Updates Fludarabine Phosphate Labeling for CLL Treatment

FDA Updates Fludarabine Phosphate Labeling for CLL Treatment